Program Goals

This activity is designed to meet the educational needs of healthcare and laboratory professionals involved in the research, diagnosis and treatment of Multiple Myeloma.

Target Audience

Hematology oncologists, hematopathologists, clinical laboratory and other healthcare professionals interested in the management of multiple myeloma patients.

Educational Objectives

After completing this activity, the participant should be able to:
  1. Review recent clinical data regarding the importance of genetic information and chromosomal anomalies in risk stratification of Multiple Myeloma patients.
  2. Summarize new and emerging treatment options for Multiple Myeloma.
  3. Discuss how risk stratification can be applied to treatment decisions for current and emerging Multiple Myeloma therapies.
  4. Understand how genetics will be taken into consideration for the design of future clinical trials and therapeutics in myeloma.

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Medical Education Collaborative (MEC) and Dane Garvin Ltd. Medical Education Collaborative is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation – Physician, CME

Medical Education Collaborative designates this educational activity for a maximum of 1.25 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Credit Designation – Lab Professional, P.A.C.E.®

The American Society for Clinical Laboratory Science’s Professional Acknowledgment for Continuing Education (P.A.C.E.®) Program will provide 1.0 contact hour of credit

Commercial Support Statement

This activity is supported by an educational grant from Abbott Molecular.

Faculty

Rafael Fonseca, M.D.
Mayo Clinic Scottsdale
Consultant, Associate Professor of Medicine
Site Director for Hematological Malignancies
Scottsdale, Arizona

Disclosure of Conflicts of Interests

Medical Education Collaborative requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Medical Education Collaborative for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations

Faculty Disclosures

Name Type Commercial Supporter
Rafael Fonseca, M.D.
Consultant
Patent Holder 		Abbott Molecular
FISH probes in Myeloma
Employees of Medical Education Collaborative, the accredited provider for this activity, have disclosed that they have no significant financial relationships.

How to Obtain CME Credit

Viewers are expected to visit all presentations before attempting to take the test and activity evaluation. Successful completion will lead to the issuance of a certificate for 1.0 AMA PRA Category 1 Credit(s) ™. To receive credit, the course must be completed before December 2007.

If you attended the live presentation on October 11, 2006, and have received CME credit for this program, you are not eligible for additional credit.

Participation in this activity should be completed in approximately 1.0 hours. Please follow these steps in order to receive CME credit for viewing the webcast:
  • Read all of the CME accreditation information above.
  • View the complete webcast program.
  • Click on the link to apply for CME credits.
  • Complete the online registration (registration is free).
  • Complete the online test and/or evaluation. Participants must receive a test score of at least 70% and answer all evaluation questions to receive a certificate.
  • After successfully completing the online test and evaluation, your application will be processed by the CME provider and your certificate will be sent to you. Please allow 3-4 weeks for this process.

Should you have any CME questions regarding this activity, please contact:
Medical Education Collaborative
651 Corporate Circle, Suite 104
Golden, CO 80401
866.420.3252 (toll free)
303.420.3259 (fax)
http://www.meccme.org/

How to Obtain P.A.C.E.® Credit

Viewers are expected to complete the presentation before attempting to submit contact information and the session evaluation. Successful completion will lead to the issuance of a certificate for 1.0 contact hour of P.A.C.E.® approved continuing education. To receive credit, the course must be completed before December 2007. No post-test is required through April 30, 2007; after that date a quiz must be completed to earn credit.

If you attended the live presentation on October 11, 2006, and have already received P.A.C.E.® credit for this program, you are not eligible for additional credit.

Participation in this activity should be completed in approximately 1.0 hours. Please follow these steps in order to receive P.A.C.E.® credit for viewing the webcast:

  • Read all of the information above.
  • View the complete webcast program.
  • Click on the link to apply for P.A.C.E.® credit.
  • Complete the online registration (registration is free).
  • Complete the online test and/or evaluation. Participants must receive a test score of at least 70% (if taken after December 27, 2006) and answer all evaluation questions to receive a certificate.
  • After successfully completing the online test and/or evaluation, your application will be processed by the CME provider and your certificate will be sent to you. Please allow 3-4 weeks for this process.

Should you have any P.A.C.E.® questions regarding this activity, please contact:
ASCLS P.A.C.E.®
6701 Democracy Blvd., Suite 300
Bethesda, MD 20817-1574
Ph: 301-657-2768
Fx: 301-657-2909
http://www.ascls.org/

For technical difficulties, please consult our Technical Instructions.

Release date: October 2006
Expiration date: October 2007


"Genetics of Myeloma: Clinical Implications"